Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor

Journal of Cell Biology

Volumn 138, Issue 4, 1997, Pages 747-758

  Dempsey, Peter J ^a   Meise, Katherine S ^a   Yoshitake, Yoshino ^b   Nishikawa, Katsuzo ^b   Coffey, Robert J ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c Vanderbilt Univ School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; BREFELDIN A; CELL MEMBRANE PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; METALLOPROTEINASE INHIBITOR; MONENSIN; PROTEIN PRECURSOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; APICAL MEMBRANE; BASOLATERAL MEMBRANE; CELL STRAIN; CONTROLLED STUDY; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; CELL POLARITY; DOGS; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SPACE; HUMANS; HYDROLYSIS; KIDNEY; METALLOENDOPEPTIDASES; MOLECULAR WEIGHT; PHENYLALANINE; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SOLUBILITY; THIOPHENES;

ANIMALIA;

EID: 0030857115     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.138.4.747     Document Type: Review

References (57)

1. Arribas, J., and J. Massagué. 1995. Transforming growth factor-α and β-amyloid precursor protein share a secretory mechanism. J. Cell Biol. 128:433-441.
2. Arribas, J., L. Coodly, P. Vollmer, T. Kishimoto, S. Rose-John, and J. Massagué. 1996. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271:11376-11382.
3. Barnard, J., R. Beauchamp, W. Russell, R. DuBois, and R. Coffey. 1995. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology. 108:564-580.
4. Baselga, J., J. Mendelsohn, Y.-M. Kim, and A. Pandiella. 1996. Autocrine regulation of membrane transforming growth factor-α cleavage. J. Biol. Chem. 271:3279-3284.
5. Bell, G., N. Fong, M. Stempien, M. Wormsted, D. Caput, L. Ku, M. Urdea, L. Rall, and R. Sanchez-Pescador. 1986. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res. 14:8427-8446.
6. Black, R., C. Rauch, C. Kozlosky, J. Peschon, J. Slack, M. Wolfson, B. Castner, K. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature (Lond.). 385:729-733.
7. Bosenherg, M., A. Pandiella, and J. Massagué. 1992. The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGFα into soluble growth factor. Cell. 71:1157-1165.
8. Bosenberg, M., A. Pandiella, and J. Massagué. 1993. Activated release of membrane-anchored TGFα in the absence of cytosol. J. Cell Biol. 122: 95-101.
9. Brandli, A., E. Adamson, and K. Simons. 1991. Transcytosis of epidermal growth factor. J. Biol Chem. 266:8560-8566.
10. Brown, C., C. Teng, B. Pentecost, and R. DiAugustine. 1989. Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells. Mol. Endocrinol. 89:1077-1083.
11. Brown, P. 1995. Matrix metalloproteinase inhibitors: a novel class of anti-cancer agents. Adv. Enzyme Regul. 35:293-301.
12. Burgess, T., and R. Kelly. 1987. Constitutive and regulated secretion of proteins. Annu. Rev. Cell Biol. 3:243-293.
13. Carpenter, G., and S. Cohen. 1979. Epidermal growth factor. Annu. Rev. Biochem. 48:193-216.
14. Carpenter, G., and M. Wahl. 1990. The epidermal growth factor family. In Peptide Growth Factors and Their Receptors. Vol. I. M. Sporn and A. Roberts, editors. Springer-Verlag, Berlin. 69-171.
15. Davies, B., P. Brown, N. East, M. Crimmin, and F. Balkwill. 1993. A synthetic matrix metalloprotease inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53:2087-2091.
16. Dempsey, P., and R. Coffey. 1994. Basolateral targeting and efficient consumption of transforming growth factor-α when expressed in Madin-Darby canine kidney cells. J. Biol. Chem. 269:16878-16889.
17. Derynck, R. 1992. The physiology of transforming growth factor-α. Cancer Res. 58:27-52.
18. Drubin, D., and W. Nelson. 1996. Origins of cell polarity. Cell. 84:335-344.
19. Ehlers, M., and J. Riordan. 1991. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry. 30:10065-10074.
20. Fiedler, K., and K. Simons. 1995. The role of N-glycans in the secretory pathway. Cell. 81:309-312.
21. Gearing, A., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. Davidson, A. Drummond, W. Galloway, R. Gilbert, J. Gordon, et al. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature (Lond.). 370:555-557.
22. Goishi, K., S. Higashiyama, M. Klagsbrun, N. Nakano, T. Umata, M. Ishikawa, E. Mekada, and N. Taniguchi. 1995. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell. 6:967-980.
23. +-ATPase in polarized epithelial cells. Science (Wash. DC). 254: 847-850.
24. Hobert, M., and C. Carlin. 1995. Cytoplasmic juxtamembrane domain of the human EGF receptor is required for basolateral localization in MDCK cells. J. Cell Physiol. 162:434-446.
25. Hooper, N., E. Karran, and A. Turner. 1997. Membrane protein secrelases. Biochemistry. 321:265-279.
26. Jahnke, G., J. Chao, M. Walker, and R. DiAugustine. 1994. Detection of a kallikrein in the mouse lactating mammary gland: a possible processing enzyme for the epidermal growth factor precursor. Growth Fact. 11:113-123.
27. Jorgensen, P., S. Hilchey, E. Nexo, S. Poulsen, and C. Quilley. 1993. Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J. Endocrinol. 130:227-234.
28. Jorgensen, P., E. Nexo, S. Poulsen, M. Almendingen, and T. Berg. 1994. Processing of epidermal growth factor in the rat submandibular gland by kallikrein-like enzymes. Growth Fact. 11:113-123.
29. Klausner, R., J. Donaldson, and J. Lippincott-Schwartz. 1992. Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116:1071-1080.
30. Lakshmanan, J., E. Salido, R. Lam, and D. Fisher. 1992. Epidermal growth factor prohormone is secreted in human urine. Am. J. Physiol Endocrinol. Metab. 26:E142-E150.
31. Lanzrein, M., O. Garred, S. Olsnes, and K. Sandvig. 1995. Diphtheria toxin endocytosis and membrane translocation are dependent on the intact membrane-anchored receptor (HB-EGF precursor): studies on the cell-associated receptor cleaved by a metalloprotease in phorbol-ester-treated cells. Biochem. J. 310:285-289.
32. Lee, D., S. Fenton, E. Berkowitz, and M. Hissong. 1995. Transforming growth factor-α: expression, regulation, and biological activities. Pharmacol. Rev. 47:51-85.
33. Margolius, H. 1984. The kallikrein-kinin system and the kidney. Annu. Rev. Physiol. 46:309-326.
34. Matlin, K., and K. Simons. 1983. Reduced temperature prevents transfer of a membrane glycoprotein to the cell surface but does not prevent terminal glycosylation. Cell. 34:233-243.
35. Mays, R., K. Siemers, B. Fritz, A. Lowe, G.V. Meer, and W. Nelson. 1995. Hierarchy of mechanisms in generating Na/K-ATPase polarity in MDCK epithelial cells. J. Cell Biol. 130:1105-1115.
36. Moss, M., S. Jin, M. Milla, W. Burkhart, H. Carter, W. Chen, W. Clay, J. Didsbury, D. Hassler, C. Hoffman, et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature (Lond.). 385:733-736.
37. Mostov, K., and M. Cardone. 1995. Regulation of protein traffic in polarized epithelial cells. BioEssays. 17:129-138.
38. Mroczkowski, B., and M. Reich. 1993. Identification of biologically active epidermal growth factor precursor in human fluids and secretions. Endocrinology. 132:417-425.
39. Mroczkowski, B., M, Reich, J. Whittaker, G. Bell, and S. Cohen. 1988. Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells. Proc. Natl. Acad. Sci. USA. 85:126-130.
40. Mroczkowski, B., M. Reich, K. Chen, G. Bell, and S. Cohen. 1989. Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity. Mol. Cell Biol. 9:2771-2778.
41. Pandiella, A., and J. Massagué. 1991. Cleavage of the membrane precursor for transforming growth factor α is a regulated process. Proc. Natl. Acad. Sci. USA. 88:1726-1730.
42. Pandiella, A., and J. Massagué. 1991. Multiple signals activate cleavage of the membrane transforming growth factor-α precursor. J. Biol. Chem. 266:5769-5773.
43. Pandiella, A., M. Bosenberg, E. Huang, P. Besmer, and J. Massagué. 1992. Cleavage of membrane-anchored growth factors involves distinct proteolytic activities regulated through common mechanisms. J. Biol. Chem. 267:24028-24033.
44. Parries, G., K. Chen, K. Misono, and S. Cohen. 1995. The human urinary epidermal growth factor (EGF) precursor. Isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus. J. Biol. Chem. 270:27954-27960.
45. Pelham, H. 1991. Multiple targets for brefeldin A. Cell. 67:449-451.
46. Playford, R., A. Woodman, P. Clark, P. Watanapa, D. Vesey, P. Deprez, R. Williamson, and J. Calam. 1993. Effect of luminal growth factor preservation on intestinal growth [see comments]. Lancet (N. Am. Ed.). 341:866-867.
47. Raab, G., S. Higashiyama, S. Hetelekidis, J. Abraham, D. Damm, M. Ono, and M. Klagsbrun. 1994. Biosynthesis and processing by phorbol ester of the cell surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem. Biophys. Res. Commun. 204:592-597.
48. Rall, L., J. Scott, G. Bell, R. Crawford, J. Penschow, H. Niall, and J. Coghlan. 1985. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature (Lond.). 313:228-231.
49. Rodriguez-Boulan, E., and S. Powell. 1992. Polarity of epithelial and neuronal cells. Annu. Rev. Cell Biol. 8:395-427.
50. + channel (arENaC) mediates its localization at the apical membrane. EMBO (Eur. Mol. Biol. Organ.) J. 13:4440-4450.
51. Salido, E., L. Barajas, J. Lechago, N. Laborde, and D. Fisher. 1986. Immunocytochemical localization of epidermal growth factor in mouse kidney. J. Histochem. Cytochem. 34:1155-1160.
52. Salido, E., D, Fisher, and L. Barajas. 1986. Immunoelectron microscopy of epidermal growth factor in mouse kidney. J Ultrastruct. Mol. Struct. Res. 96:105-113.
53. Salido, E., P. Yen, L. Shapiro, D. Fisher, and L. Barajas. 1989. In situ hybridization of prepro-epidermal growth factor mRNA in the mouse kidney. Am. J. Physiol. 256:F632-F63K.
54. Wolfsberg, T., P. Primakoff, D. Myles, and J. White. 1995. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131:275-278.
55. Wollner, D., and W. Nelson. 1992. Establishing and maintaining epithelial cell polarity - roles of protein sorting, delivery, and retention. J. Cell Sci. 102:185-190.
56. Wollner, D., K. Krzeminski, and W. Nelson. 1992. Remodeling the cell surface distribution of membrane proteins during the development of epithelial cell polarity. J. Cell Biol. 116:889-899.
57. Yoshitake, Y., and K. Nishikawa. 1988. Production of monoclonal antibodies with specificity for different epitopes on the human epidermal growth factor molecule. Arch. Biochem. Biophys. 263:437-446.